BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #628Biotechnology
$50.60 −$0.75 (-1.46%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $50.02 -1.15%
Open$51.57
Prev close$51.35
Day range$50.24 – $51.72
Volume2.90M
Market cap$31.20B
P/E (TTM)43.2
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$64.57+27.6% vs. price
  • Buy 89%
  • Hold 11%
Low $52.00Now $50.60Avg $64.57High $80.00

Recent rating changes

The last 20 actions on file set price targets from $50.00 to $80.00, averaging $63.07.

DateFirmRatingTarget
13 Nov 2026 Morgan Stanley HOLD $56.00
6 Nov 2026 BofA Securities BUY –
6 Nov 2026 Truist Financial BUY $67.00
6 Nov 2026 Morgan Stanley HOLD $57.00
6 Nov 2026 H.C. Wainwright BUY $70.00
1 Nov 2026 BofA Securities BUY –
30 Oct 2026 Morgan Stanley HOLD $57.00
30 Oct 2026 H.C. Wainwright BUY $70.00
29 Oct 2026 William Blair BUY –
29 Oct 2026 Truist Financial BUY $67.00
29 Oct 2026 Goldman Sachs BUY $62.00
29 Oct 2026 Guggenheim BUY $80.00
29 Oct 2026 Leerink Partners BUY $65.00
29 Oct 2026 H.C. Wainwright BUY $70.00
28 Oct 2026 BofA Securities BUY –
27 Oct 2026 Leerink Partners BUY $60.00
26 Oct 2026 TD Cowen BUY $52.00
26 Oct 2026 BofA Securities BUY –
26 Oct 2026 H.C. Wainwright BUY $50.00
23 Oct 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on GMAB.

Sign in to join the discussion.

Scroll to Top